Literature DB >> 2726824

The role of aldehyde dehydrogenase isozymes in cellular resistance to the alkylating agent cyclophosphamide.

J E Russo1, J Hilton, O M Colvin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2726824

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  10 in total

1.  Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity.

Authors:  R W Storms; A P Trujillo; J B Springer; L Shah; O M Colvin; S M Ludeman; C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells.

Authors:  John P Chute; Garrett G Muramoto; John Whitesides; Michael Colvin; Rachid Safi; Nelson J Chao; Donald P McDonnell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-20       Impact factor: 11.205

Review 3.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  M J Moore
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 4.  The importance of both CYP2C19 and CYP2B6 germline variations in cyclophosphamide pharmacokinetics and clinical outcomes.

Authors:  N A Helsby; M Yong; M van Kan; J R de Zoysa; K E Burns
Journal:  Br J Clin Pharmacol       Date:  2019-07-22       Impact factor: 4.335

Review 5.  Cyclophosphamide and cancer: golden anniversary.

Authors:  Ashkan Emadi; Richard J Jones; Robert A Brodsky
Journal:  Nat Rev Clin Oncol       Date:  2009-09-29       Impact factor: 66.675

6.  Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines.

Authors:  Q Dong; N Bullock; F Ali-Osman; O M Colvin; D D Bigner; H S Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

7.  Liposarcoma Cells with Aldefluor and CD133 Activity have a Cancer Stem Cell Potential.

Authors:  Eva W Stratford; Russell Castro; Anna Wennerstrom; Ruth Holm; Else Munthe; Silje Lauvrak; Bodil Bjerkehagen; Ola Myklebost
Journal:  Clin Sarcoma Res       Date:  2011-08-01

8.  Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy.

Authors:  Scott J Dylla; Lucia Beviglia; In-Kyung Park; Cecile Chartier; Janak Raval; Lucy Ngan; Kellie Pickell; Jorge Aguilar; Sasha Lazetic; Stephanie Smith-Berdan; Michael F Clarke; Tim Hoey; John Lewicki; Austin L Gurney
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

9.  Investigating critical genes and gene interaction networks that mediate cyclophosphamide sensitivity in chronic myelogenous leukemia.

Authors:  Xiao He; Yuying Deng; Wei Yue
Journal:  Mol Med Rep       Date:  2017-05-26       Impact factor: 2.952

10.  APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH+ stem cells that alters GLP-2 and SST feedback signaling: Clue to a link between WNT and retinoic acid signalling in colon cancer development.

Authors:  Tao Zhang; Koree Ahn; Brooks Emerick; Shirin R Modarai; Lynn M Opdenaker; Juan Palazzo; Gilberto Schleiniger; Jeremy Z Fields; Bruce M Boman
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.